Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Intestinal Carcinoma

NCT06979882 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06979882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06979882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Intestinal Carcinoma
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
May 25, 2025
Completion date
March 1, 2030
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

intestinal cancer